Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Recruiting 4Completed 4Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 36Gastrointestinal 18CNS 7Thoracic 6Breast 6Endocrine 5Tumor-Agnostic 4Head & Neck 4Gynecologic 4Sarcoma 3Dermatologic 3Plasma cell 2Other solid neoplasm 2NET 2Other hematologic neoplasm 1

Conditions

Neoplasms 3Neoplasm Metastasis 2

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × cabozantinib × Tumor-Agnostic × Clear all
NCT03611595 2026-05-27

Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors

University of California, San Diego

Phase 1 Completed
15 enrolled
Tumor-Agnostic

Neoplasms

NCT01979393 2025-08-01

IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
58 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01553656 2015-08-20

Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer

Exelixis

Phase 1 Completed
85 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT01018745 2011-01-07

Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

Bristol-Myers Squibb

Phase 1 Completed
3 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡